nortriptyline hydrochloride capsule
unit dose services - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 25 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recovery period
nortriptyline hydrochloride solution
taro pharmaceuticals u.s.a., inc. - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - solution - 10 mg in 5 ml - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the concurrent use of nortriptyline hydrochloride or other tricyclic antidepressants with a monoamine oxidase (mao) inhibitor is contraindicated. hyperpyretic crises, severe convulsions, and fatalities have occurred when similar tricyclic antidepressants were used in such combinations. it is advisable to discontinue the mao inhibitor at least 2 weeks before treatment with nortriptyline hydrochloride is to be started. patients hypersensitive to nortriptyline hydrochloride should not be given the drug. cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recovery period after myocardial infarction.
nortriptyline 10 mg film-coated tablets
pharmafile limited - nortriptyline - film-coated tablet - 10 milligram(s) - nortriptyline
amitriptyline hydrochloride 25mg/5ml oral solution
wockhardt uk limited - amitriptyline hydrochloride - oral solution - amitriptyline hydrochloride 25 milligram(s)/5 millilitre - psychoanaleptics
amitriptyline hydrochloride 50mg/5ml oral solution
wockhardt uk limited - amitriptyline hydrochloride - oral solution - amitriptyline hydrochloride 50 milligram(s)/5 millilitre - psychoanaleptics
nortritabs nortriptyline (as hydrochloride) 10 mg uncoated tablet blister pack
amdipharm mercury australia pty ltd - nortriptyline hydrochloride, quantity: 11.4 mg (equivalent: nortriptyline, qty 10 mg) - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch - treatment of major depression
nortritabs nortriptyline (as hydrochloride) 25 mg uncoated tablet blister pack
amdipharm mercury australia pty ltd - nortriptyline hydrochloride, quantity: 28.5 mg (equivalent: nortriptyline, qty 25 mg) - tablet, uncoated - excipient ingredients: maize starch; lactose monohydrate; magnesium stearate - treatment of major depression
nortriptyline chanelle medical 25 mg film-coated tablets
chanelle medical unlimited company - nortriptyline hydrochloride - film-coated tablet - 25 milligram(s) - non-selective monoamine reuptake inhibitors; nortriptyline
nortriptyline chanelle medical 10 mg film-coated tablets
chanelle medical unlimited company - nortriptyline hydrochloride - film-coated tablet - 10 milligram(s) - non-selective monoamine reuptake inhibitors; nortriptyline
nortriptyline 10 mg film-coated tablets
alissa healthcare research limited - nortriptyline hydrochloride - film-coated tablet - 10 milligram(s) - non-selective monoamine reuptake inhibitors; nortriptyline